Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apyx Medical (APYX) Net Margin (2016 - 2025)

Historic Net Margin for Apyx Medical (APYX) over the last 15 years, with Q3 2025 value amounting to 15.41%.

  • Apyx Medical's Net Margin rose 255300.0% to 15.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 30.35%, marking a year-over-year increase of 282400.0%. This contributed to the annual value of 48.78% for FY2024, which is 130300.0% down from last year.
  • Per Apyx Medical's latest filing, its Net Margin stood at 15.41% for Q3 2025, which was up 255300.0% from 33.22% recorded in Q2 2025.
  • Apyx Medical's 5-year Net Margin high stood at 7.51% for Q2 2023, and its period low was 73.96% during Q1 2024.
  • Its 5-year average for Net Margin is 41.46%, with a median of 40.94% in 2024.
  • Its Net Margin has fluctuated over the past 5 years, first soared by 730800bps in 2021, then crashed by -464500bps in 2024.
  • Over the past 5 years, Apyx Medical's Net Margin (Quarter) stood at 11.95% in 2021, then crashed by -303bps to 48.09% in 2022, then crashed by -36bps to 65.52% in 2023, then surged by 50bps to 32.54% in 2024, then surged by 53bps to 15.41% in 2025.
  • Its Net Margin stands at 15.41% for Q3 2025, versus 33.22% for Q2 2025 and 44.01% for Q1 2025.